149 related articles for article (PubMed ID: 38061956)
1. Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines.
Chokephaibulkit K; Puthanakit T; Chaithongwongwatthana S; Bhat N; Tang Y; Anugulruengkitt S; Chayachinda C; Anuwutnavin S; Lapphra K; Rungmaitree S; Tawan M; Andi-Lolo I; Holt R; Fortuna L; Kerdsomboon C; Yuwaree V; Mansouri S; Thai PH; Innis BL
Vaccine; 2024 Jan; 42(2):383-395. PubMed ID: 38061956
[TBL] [Abstract][Full Text] [Related]
2. A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women.
Puthanakit T; Chokephaibulkit K; Chaithongwongwatthana S; Bhat N; Tang Y; Anugulruengkitt S; Chayachinda C; Anuwutnavin S; Lapphra K; Rungmaitree S; Tawan M; Andi-Lolo I; Holt R; Fortuna L; Kerdsomboon C; Yuwaree V; Mansouri S; Thai PH; Innis BL
Vaccine; 2023 Jul; 41(31):4541-4553. PubMed ID: 37330371
[TBL] [Abstract][Full Text] [Related]
3. A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age.
Chokephaibulkit K; Puthanakit T; Bhat N; Mansouri S; Tang Y; Lapphra K; Rungmaitree S; Anugulruengkitt S; Jantarabenjakul W; Andi-Lolo I; Holt R; Fortuna L; Kerdsomboon C; Chinwangso P; Suwitruengrit L; van den Biggelaar AHJ; Viviani S; Pham HT; Innis BL
Vaccine; 2022 Apr; 40(15):2352-2361. PubMed ID: 34789403
[TBL] [Abstract][Full Text] [Related]
4. A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.
Sricharoenchai S; Sirivichayakul C; Chokephaibulkit K; Pitisuttithum P; Dhitavat J; Pitisuthitham A; Phongsamart W; Boonnak K; Lapphra K; Sabmee Y; Wittawatmongkol O; Chinwangso P; Poredi IK; Petre J; Thai PH; Viviani S
Lancet Infect Dis; 2018 Jan; 18(1):58-67. PubMed ID: 29066131
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.
Sirivichayakul C; Chanthavanich P; Limkittikul K; Siegrist CA; Wijagkanalan W; Chinwangso P; Petre J; Hong Thai P; Chauhan M; Viviani S
Hum Vaccin Immunother; 2017 Jan; 13(1):136-143. PubMed ID: 27686283
[TBL] [Abstract][Full Text] [Related]
6. Pertussis antibody levels in infants and their mothers receiving combined tetanus-diphtheria toxoid and acellular pertussis vaccine during pregnancy in Turkey.
Ozdil M; Sonmez C; Tugberk Bakar M; Alici Davutoglu E; Madazli R; Kilic S; Vural M; Perk Y
Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():212-216. PubMed ID: 34534737
[TBL] [Abstract][Full Text] [Related]
7. Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial.
Wanlapakorn N; Maertens K; Vongpunsawad S; Puenpa J; Tran TMP; Hens N; Van Damme P; Thiriard A; Raze D; Locht C; Poovorawan Y; Leuridan E
Clin Infect Dis; 2020 Jun; 71(1):72-80. PubMed ID: 31418814
[TBL] [Abstract][Full Text] [Related]
8. Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial.
Pitisuttithum P; Chokephaibulkit K; Sirivichayakul C; Sricharoenchai S; Dhitavat J; Pitisuthitham A; Phongsamart W; Boonnak K; Lapphra K; Sabmee Y; Wittawatmongkol O; Chauhan M; Wijagkanalan W; Hommalai G; Fortuna L; Chinwangso P; Poredi IK; van den Biggelaar AHJ; Pham HT; Viviani S
Lancet Infect Dis; 2018 Nov; 18(11):1260-1268. PubMed ID: 30266329
[TBL] [Abstract][Full Text] [Related]
9. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
Ladhani SN; Andrews NJ; Southern J; Jones CE; Amirthalingam G; Waight PA; England A; Matheson M; Bai X; Findlow H; Burbidge P; Thalasselis V; Hallis B; Goldblatt D; Borrow R; Heath PT; Miller E
Clin Infect Dis; 2015 Dec; 61(11):1637-44. PubMed ID: 26374816
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial.
Wood N; Nolan T; Marshall H; Richmond P; Gibbs E; Perrett K; McIntyre P
JAMA Pediatr; 2018 Nov; 172(11):1045-1052. PubMed ID: 30208475
[TBL] [Abstract][Full Text] [Related]
11. Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen®) vaccine for immunization of adolescents and adults in Thailand.
Fortuna L; Chaithongwongwatthana S; Soonthornworasiri N; Spiegel J; Wijagkanalan W; Mansouri S; van den Biggelaar AHJ; Pham HT
Vaccine; 2020 Dec; 38(51):8194-8199. PubMed ID: 33176935
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of maternal pertussis-specific antibodies in infants of mothers vaccinated with tetanus, diphtheria and acellular pertussis (Tdap) during pregnancy.
Healy CM; Rench MA; Swaim LS; Timmins A; Vyas A; Sangi-Haghpeykar H; Ng N; Rajam G; ; Havers F; Schiffer J; Baker CJ
Vaccine; 2020 Aug; 38(37):5955-5961. PubMed ID: 32709433
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Maternal Pertussis Immunization on Infant Vaccine Responses to a Booster Pertussis-Containing Vaccine in Vietnam.
Maertens K; Hoang TT; Nguyen TD; Caboré RN; Duong TH; Huygen K; Hens N; Van Damme P; Dang DA; Leuridan E
Clin Infect Dis; 2016 Dec; 63(suppl 4):S197-S204. PubMed ID: 27838673
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.
Munoz FM; Bond NH; Maccato M; Pinell P; Hammill HA; Swamy GK; Walter EB; Jackson LA; Englund JA; Edwards MS; Healy CM; Petrie CR; Ferreira J; Goll JB; Baker CJ
JAMA; 2014 May; 311(17):1760-9. PubMed ID: 24794369
[TBL] [Abstract][Full Text] [Related]
15. Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination During Pregnancy: Impact on Infant Anti-Pertussis Antibody Concentrations by Maternal Pertussis Priming Series.
Havers FP; Skoff TH; Rench MA; Epperson M; Rajam G; Schiffer J; Hariri S; Swaim LS; Baker CJ; Healy CM
Clin Infect Dis; 2023 Feb; 76(3):e1087-e1093. PubMed ID: 35642525
[TBL] [Abstract][Full Text] [Related]
16. A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults.
Leroux-Roels G; Lattanzi M; Solis CD; Contorni M; Costantini M; Moraschini L; Bardelli M; Bertholet S; Borgogni E; Buricchi F; Cantisani R; Faenzi E; Finco O; Leuzzi R; Pizza M; Rosa D; Schiavetti F; Seubert A; Spensieri F; Volpini G; Zedda L; Giudice GD; Galgani I
Hum Vaccin Immunother; 2018 Jan; 14(1):45-58. PubMed ID: 29172945
[TBL] [Abstract][Full Text] [Related]
17. Pertussis, diphtheria, and tetanus antibodies seroprevalence in pregnant women and neonates, as a preliminary data for introduction of preconception or prenatal DTaP vaccination among Japanese society.
Tsurane K; Umehara N; Nakayama T; Okada K; Inoue M; Ogawa K; Sago H; Miyasaka N; Yamaguchi K
Vaccine; 2022 Nov; 40(49):7122-7129. PubMed ID: 36404430
[TBL] [Abstract][Full Text] [Related]
18. A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response.
Halperin SA; Langley JM; Ye L; MacKinnon-Cameron D; Elsherif M; Allen VM; Smith B; Halperin BA; McNeil SA; Vanderkooi OG; Dwinnell S; Wilson RD; Tapiero B; Boucher M; Le Saux N; Gruslin A; Vaudry W; Chandra S; Dobson S; Money D
Clin Infect Dis; 2018 Sep; 67(7):1063-1071. PubMed ID: 30010773
[TBL] [Abstract][Full Text] [Related]
19. Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
Blanchard Rohner G; Chatzis O; Chinwangso P; Rohr M; Grillet S; Salomon C; Lemaître B; Boonrak P; Lawpoolsri S; Clutterbuck E; Poredi IK; Wijagkanalan W; Spiegel J; Pham HT; Viviani S; Siegrist CA
Clin Infect Dis; 2019 Mar; 68(7):1213-1222. PubMed ID: 30759183
[TBL] [Abstract][Full Text] [Related]
20. Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.
Caboré RN; Maertens K; Dobly A; Leuridan E; Van Damme P; Huygen K
Virulence; 2017 Oct; 8(7):1245-1254. PubMed ID: 28277900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
